Cynapsus Therapeutic (CYNAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CYNAF | IKT | PRLD | ||
| Company | Cynapsus Therapeutic | Inhibikase Therapeutics Inc | Prelude Therapeutics Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 0.9984 | 1.5500 | 1.6200 | ||
| High | 0.9984 | 1.5600 | 1.7200 | ||
| Low | 0.9600 | 1.5000 | 1.6021 | ||
| Latest | 0.9600 | 1.5400 | 1.7100 | ||
| Change | -0.0330 | +0.0150 | +0.0800 | ||
| % Change | -3.32% | +0.98% | +4.91% | ||
| Volume | 31,200 | 642,100 | 341,600 | ||
| 20-Day Average Volume | N/A | 435,260 | 406,755 | ||
| Previous Close | 0.9930 | 1.5250 | 1.6300 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | N/A | 1.5108 | 1.5777 | ||
| 20-Day Raw Stochastic | N/A | 53.85% | 95.40% | ||
| 20-Day Relative Strength | N/A | 50.27 | 53.08 | ||
| Weighted Alpha | N/A | -50.74 | +3.05 | ||
| Today's Opinion | N/A | 88% Sell | 96% Buy | ||
| Previous Opinion | N/A | 88% Sell | 96% Buy | ||
| Last Month's Opinion | N/A | 64% Sell | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.32% since 04/18/16 | +2.67% since 12/05/25 | +17.12% since 12/05/25 | ||
| Low | 0.9600 on 05/09/16 | 1.4300 on 12/08/25 | 1.4500 on 12/08/25 | ||
| High | 0.9984 on 05/09/16 | 1.5689 on 12/11/25 | 1.7200 on 12/12/25 | ||
| 1-Month | |||||
| %Chg | -9.18% since 02/24/14 | -4.94% since 11/12/25 | +16.33% since 11/12/25 | ||
| Low | 0.9494 on 04/18/16 | 1.4000 on 12/03/25 | 1.2950 on 12/03/25 | ||
| High | 1.0872 on 04/18/16 | 1.6600 on 11/21/25 | 1.7300 on 11/18/25 | ||
| 3-Month | |||||
| %Chg | N/A since 02/24/14 | -1.28% since 09/12/25 | +51.33% since 09/12/25 | ||
| Low | 0.9494 on 04/18/16 | 1.3300 on 11/03/25 | 0.9807 on 09/19/25 | ||
| High | 1.0872 on 04/18/16 | 1.7800 on 09/19/25 | 4.2200 on 11/03/25 | ||
| 6-Month | |||||
| %Chg | N/A since 02/24/14 | -19.37% since 06/12/25 | +64.42% since 06/12/25 | ||
| Low | 0.9494 on 04/18/16 | 1.3300 on 11/03/25 | 0.7500 on 08/12/25 | ||
| High | 1.0872 on 04/18/16 | 2.0900 on 07/09/25 | 4.2200 on 11/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 107,680 | 115,770 | 107,499 | ||
| Shares Outstanding, K | 110,310 | 75,175 | 62,865 | ||
| Annual Sales | 0 | 0 | 7,000,000 | ||
| Annual Net Income | 9,800,000 | -27,520,000 | -127,170,000 | ||
| Last Quarter Sales | 0 | 0 | 6,500,000 | ||
| Last Quarter Net Income | -4,220,000 | -11,930,000 | -19,730,000 | ||
| 60-Month Beta | 1.71 | 0.88 | 1.06 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.13 on 11/14/25 | -0.26 on 11/12/25 | ||
| Latest Earnings Date | 08/12/15 | 03/26/26 | 03/09/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||